title: Adverse Drug Event Prevention: 2014 Action Plan Conference.
abstract: Adverse drug events (ADEs) have been highlighted as a national patient safety and public health challenge by the National Action Plan for Adverse Drug Event Prevention (ADE Action Plan), which was released by the Office of Disease Prevention and Health Promotion in August 2014. The following October, the ADE Prevention: 2014 Action Plan Conference provided an opportunity for federal agencies, national experts, and stakeholders to coordinate and collaborate in the initiative to reduce preventable ADEs. The single-day conference included morning plenary sessions focused on the surveillance, evidence-based prevention, incentives and oversights, and additional research needs of the drug classes highlighted in the ADE Action Plan: anticoagulants, diabetes agents, and opioids. Afternoon breakout sessions allowed for facilitated discussions on measures for tracking national progress in ADE prevention and the identification of opportunities to ensure safe and high-quality health care and medication use.
authors.affiliation: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, MD.
authors.forename: Aaron R
authors.initials: AR
authors.lastname: Ducoffe
authors.affiliation: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, MD Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
authors.forename: Avi
authors.initials: A
authors.lastname: Baehr
authors.affiliation: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, MD.
authors.forename: Juliet C
authors.initials: JC
authors.lastname: Peña
authors.affiliation: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, MD.
authors.forename: Briana B
authors.initials: BB
authors.lastname: Rider
authors.affiliation: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, MD.
authors.forename: Sandra
authors.initials: S
authors.lastname: Yang
authors.affiliation: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, MD Dale.Hu@nih.gov.
authors.forename: Dale J
authors.initials: DJ
authors.lastname: Hu
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D003226:Congresses as Topic; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D058996:Quality Improvement / Q000458:organization & administration*; D014481:United States / Q000453:epidemiology
chemical_list: D000701:Analgesics, Opioid; D000925:Anticoagulants; D007004:Hypoglycemic Agents
keywords: adverse drug events; anticoagulants; diabetes agents; opioids; quality